RAS Mutation Detection Kit Market
RAS Mutation Detection Kit Market Study by PCR-Based Kits, Sequencing-Based Kits, and Hybridization & Allele-specific PCR from 2024 to 2034
Analysis of RAS Mutation Detection Kit Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
RAS Mutation Detection Kit Market Outlook (2024 to 2034)
The global RAS mutation detection kit market size is set to be valued at US$ 118.7 million in 2024 and is projected to expand at a noteworthy CAGR of 7.6% to reach US$ 246.7 million by 2034-end.
RAS mutation detection kits are specialized laboratory instruments designed to detect changes in the RAS gene family, a set of genes commonly altered in different types of cancer like colorectal cancer or pancreatic cancer. RAS mutations affect how cells divide and proliferate, which may result in undiagnosed cell growth and the development of tumors. The RAS mutation gene can be further divided into three major types namely KRAS, NRAS, and HRAS mutation genes.
- The KRAS type is estimated to hold a leading market share of 76.5% in 2024, and the segment is projected to expand at a CAGR of 7.2% during the forecast period (2024 to 2034).
Demand for RAS mutation screening kits is being bolstered by the goal of early cancer detection. To provide patients a chance of having a successful course of therapy, these kits help in identifying the patients who show symptoms as soon as possible. Cancer care that is postponed has shorter survival rates, more treatment-related problems, and higher healthcare costs.
Colorectal cancer is the most common type of cancer and exhibits the highest incidence of RAS mutation cells. Rising prevalence of these chronic diseases among the population is driving the need for advanced diagnostic testing kits for tumor marker detection. Furthermore, ongoing research and development activities in cancer diagnostics are projected to offer more diverse and effective options.
- North America is projected to account for 38.6% of the global RAS mutation detection kit market share by 2034.
- Revenue from RAS mutation analysis kit sales in Latin America is estimated to reach US$ 3.8 million in 2024.
| Report Attributes | Details |
|---|---|
| RAS Mutation Detection Kit Market Size (2024E) | US$ 118.7 Million |
| Forecasted Market Value (2034F) | US$ 246.7 Million |
| Global Market Growth Rate (2024 to 2034) | 7.6% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 7.1% CAGR |
| Chile Market Value (2034F) | US$ 1.2 Million |
| NRAS Mutation Segment Growth (2024 to 2034) | 9.1% CAGR |
| Key Companies Profiled | EntroGen, Inc.; QIAGEN; Roche Molecular Diagnostics; Bio-Rad Laboratories; Personalis, Inc.; Thermo Fisher Scientific; MBL Life Sciences; Amoy Dx; 3B BlackBio Biotech India Limited; CD Genomics |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which RAS Mutation Detection Kit Market Trends are Suppliers Benefitting from?
“Increased Patient Awareness of Role of RAS Mutation in Cancer Development”
Patients proactively seek diagnostic testing to find out whether they have an RAS mutation as awareness of this mutation's role in the development of cancer is rising. Better results may come from customized therapy regimens based on the unique genetic composition of the tumor, which is made possible by this early detection. This is why genetic testing for cancer has gained traction in recent times in the oncology diagnostics spaces.
People who are aware of the risk factors and typical symptoms of cancer are more likely to seek medical assistance as soon as they notice any anomalies. This enables early diagnosis and management at the initial stages.
“Government Initiatives Promoting Early Cancer Diagnosis and Favorable Reimbursement Policies”
Governments are starting to realize how important tailored treatment and early cancer diagnosis are. This translates into practical action in the form of RAS testing-promoting public health campaigns, infrastructure improvements in the healthcare industry, and even direct support for RAS detection technology research and development. Rising awareness and accessibility of these kits foster a favorable environment for expansion of the RAS mutation detection kit market size.
More patients can now benefit from RAS testing and genetic mutation testing because reimbursement policies are lessening the financial burden. Insurance companies are beginning to see the value of early identification and treatment.
What is Hampering Global RAS Mutation Detection Kit Market Growth?
“Technical and Operational Challenges Impeding Adoption of RAS Mutation Detection Kits”
The market faces substantial obstacles due to operational and technical issues. Even while more recent methods claim to be more accurate, certain older kits still have problems with false positives or negatives, which could be confusing and detrimental to patient treatment.
Complicated data interpretation puts more pressure on the system since it calls for specialist knowledge that isn't always available. There are logistical and budgetary obstacles when integrating RAS mutation tests into current laboratory operations and making sure the equipment is compatible. Additional investments and modifications are frequently needed.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Which Key Strategies are Proving Instrumental in Propelling New Companies to Success?
“Focus on Research Collaborations to Develop Advanced RAS Mutation Detection Kits”
New companies can take advantage of complementary strengths in research & development (R&D), assay design, production, and clinical validation by combining resources and expertise. This encourages the development of increasingly sophisticated, precise, and user-friendly RAS mutation detection kits that meet a range of requirements.
- For instance, Entrogen, Inc.'s ctDNA RAS mutation detection kit is a non-invasive, highly sensitive assay that amplifies and detects 25 clinically relevant mutations in KRAS exon 2 and NRAS exons 2 and 3 from circulating cell-free DNA obtained from human plasma.
Encouraging new businesses to actively participate in and fund clinical trials can not only aid in the creation of innovative products but also boost the company's reputation. Favorable trial results are projected to fortify the argument for regulatory endorsements and cultivate confidence among healthcare professionals.
Forming partnerships with research institutions and industry leaders facilitates the exchange of knowledge and grants access to complementary expertise. These collaborations expedite research and development activities, empowering emerging manufacturers to efficiently introduce innovative solutions to the market, thereby enhancing the availability of RAS mutation detection kits.
Country-wise Analysis
As per the analysis by Fact.MR, a market research and competitive intelligence provider, market growth in the United States, Germany, and Brazil is influenced by a combination of factors, including the presence of advanced healthcare infrastructure, next generation sequencing, research initiatives, government support, awareness campaigns, and patient access to innovative therapies.
Why are RAS Mutation Detection Kit Providers Focusing on the United States?
“Increasing Prevalence of Cancer and Enhanced Patient Access to Advanced Treatments”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 40.6 Million |
| Growth Rate (2024 to 2034) | 7.8% CAGR |
| Projected Value (2034F) | US$ 86.9 Million |
Surging cancer rates in the United States are driving a heightened need for efficient diagnostic testing targeting RAS mutations. Key contributors to the escalating cancer prevalence include the aging demographic and evolving lifestyles. Supportive reimbursement policies in the country are facilitating patient access to advanced treatment alternatives.
What is Complementing Market Growth in Germany?
“Emphasis on Research and Innovation and Collaborative Healthcare Ecosystem”
Germany's commitment to medical research and innovation is solidifying its role as a frontrunner in European healthcare. The ongoing surge in research-driven breakthroughs, particularly in cancer diagnostic testing, is playing a pivotal role in driving market expansion. The collaborative healthcare ecosystem in the country, fostering strong ties between academia, industry, and healthcare providers, is creating an ideal environment for the advancement and uptake of RAS mutation detection kits.
Why is Brazil a Lucrative Market for RAS Mutation Detection Kit Providers?
“Government Initiatives for Cancer Control Contributing to Early Detection and Treatment”
| Attribute | Brazil |
|---|---|
| Market Value (2024E) | US$ 1.7 Million |
| Growth Rate (2024 E to 2034 F) | 5.4% CAGR |
| Projected Value (2034F) | US$ 2.9 Million |
Increasing initiatives to enhance cancer awareness in Brazil are leading to early detection and treatment. Government programs dedicated to cancer control and treatment accessibility are pivotal in shaping efficient diagnostic solutions. Globally recognized events like World Cancer Day, observed annually, aim to intensify efforts for better access to top-notch care, screening, early detection, treatment, and palliative care.
Robust investments in healthcare infrastructure, awareness initiatives, and supportive policies collectively contribute to a holistic approach to the development and utilization of RAS mutation detection kits.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Category-wise Analysis
Increased demand for KRAS mutation detection kits is propelled by factors including improved effectiveness, varied treatment strategies, the rise of personalized medicine, and positive outcomes from successful clinical trials. As ongoing research and development persist, detection of the KRAS mutation gene plays a pivotal role in molding the contemporary landscape of cancer diagnostic kits.
Which RAS Type Occupies a Leading Market Share?
“Increased Incidence of Cancer Cases Due to Unchecked Proliferation Due to KRAS Mutations”
| Attribute | KRAS Type |
|---|---|
| Segment Value (2024E) | US$ 90.8 Million |
| Growth Rate (2024 to 2034) | 7.2% CAGR |
| Projected Value (2034F) | US$ 181.5 Million |
The KRAS gene, located on chromosome 12, is prone to damage from a variety of factors, such as smoking, UV radiation, and even regular biological functions. This inherent susceptibility increases the likelihood of mutations occurring in the KRAS gene. KRAS mutations frequently give cancer cells an advantage in terms of proliferation. These mutant cells outcompete their non-mutated counterparts by encouraging unchecked proliferation, which increases the number of cancer cases.
Competitive Landscape
Key players in the RAS mutation detection kit market are strategically emphasizing research excellence, forming key collaborations, expanding globally, adopting patient-centric approaches, demonstrating regulatory expertise, implementing market-specific pricing strategies, and integrating technology.
These diverse strategies are designed to enable industry leaders not just to navigate the intricacies of the market but also to stimulate innovation and make substantial contributions to the progress of RAS mutation detection kits.
Key Segments of RAS Mutation Detection Kit Market Research
-
By RAS Type :
- NRAS
- KRAS
- HRAS
-
By Application :
- Disease Diagnostics
- Prognostics
- Personalized Medicine
- Drug Discovery & Development
-
By Cancer Type :
- Breast Cancer
- Pancreatic Cancer
- Colorectal Cancer
- Lung Cancer
- Blood Cancer
- Skin Cancer
- Uterus Cancer
- Bladder Cancer
- Prostate Cancer
-
By Kit Type :
- Tissue-based Kits
- Liquid Biopsy Kits
-
By End User :
- Academic & Cancer Research Institutes
- Hospitals & Diagnostic Clinics
- Contract Research Organizations
- Pharma & Biotech Companies
-
By Detection Method :
- PCR-Based Kits
- Sequencing-Based Kits
- Hybridization and Allele-specific PCR
-
By Region :
- North America
- Latin America
- East Asia
- South Asia & Pacific
- Western Europe
- Eastern Europe
- Middle East & Africa
Table of Content
- 1. Market - Executive Summary
- 2. Market Overview
- 3. Key Market Trends
- 4. Value Added Insights
- 5. Market Background
- 6. Market Demand (in Value US$ Mn) Analysis 2019 to 2023 and Forecast, 2024 to 2034
- 7. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By RAS Type
- 7.1. NRAS
- 7.2. KRAS
- 7.3. HRAS
- 8. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Detection Methods
- 8.1. PCR Based Kits
- 8.2. Sequencing Based Kits
- 8.3. Hybridization and Allele-specific PCR
- 9. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Application
- 9.1. Disease Diagnostics
- 9.2. Prognostics
- 9.3. Personalized Medicine
- 9.4. Drug Discovery & Development
- 10. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Cancer Type
- 10.1. Breast Cancer
- 10.2. Pancreatic Cancer
- 10.3. Colorectal Cancer
- 10.4. Lung Cancer
- 10.5. Blood Cancer
- 10.6. Skin Cancer
- 10.7. Uterus Cancer
- 10.8. Bladder Cancer
- 10.9. Prostate Cancer
- 10.10. Others
- 11. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By Region
- 11.1. North America
- 11.2. Latin America
- 11.3. East Asia
- 11.4. South Asia & Pacific
- 11.5. Western Europe
- 11.6. Eastern Europe
- 11.7. Middle East & Africa (MEA)
- 12. Market Analysis 2019 to 2023 and Forecast 2024 to 2034, By End Users Vs Kits Type
- 12.1. Academic & Cancer Research Institutes
- 12.2. Hospitals & Diagnostic Clinics
- 12.3. Contract Research Organizations
- 12.4. Pharma & Biotech Companies
- 13. North America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 14. Latin America Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 15. East Asia Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 16. South Asia & Pacific Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 17. Western Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 18. Eastern Europe Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 19. Middle East & Africa Market Analysis 2019 to 2023 and Forecast 2024 to 2034
- 20. Market Structure Analysis
- 21. Competition Analysis
- 21.1. EntroGen, Inc.
- 21.2. QIAGEN N.V.
- 21.3. Roche Molecular Diagnostics
- 21.4. Bio Rad Laboratories Inc.
- 21.5. Personalis, Inc.
- 21.6. Thermo Fisher Scientific
- 21.7. MBL International Corporation (JSR Life Sciences)
- 21.8. Amoy Dx
- 21.9. 3B BlackBio Biotech India Limited
- 21.10. CD Genomics
- 21.11. Xiamen Spacegen Co., Ltd.
- 22. Assumptions and Acronyms Used
- 23. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Forecast by Region, 2019 to 2034
Table 02: Global Market Volume (Units) Forecast by Region, 2019 to 2034
Table 03: Global Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 04: Global Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 05: Global Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 06: Global Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 07: Global Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 08: Global Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 09: Global Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 10: Global Market Volume (Units) Forecast by Application, 2019 to 2034
Table 11: Global Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 12: Global Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 13: North America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 14: North America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 15: North America Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 16: North America Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 17: North America Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 18: North America Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 19: North America Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 20: North America Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 21: North America Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 22: North America Market Volume (Units) Forecast by Application, 2019 to 2034
Table 23: North America Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 24: North America Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 25: Latin America Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 26: Latin America Market Volume (Units) Forecast by Country, 2019 to 2034
Table 27: Latin America Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 28: Latin America Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 29: Latin America Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 30: Latin America Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 31: Latin America Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 32: Latin America Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 33: Latin America Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 34: Latin America Market Volume (Units) Forecast by Application, 2019 to 2034
Table 35: Latin America Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 36: Latin America Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 37: East Asia Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 38: East Asia Market Volume (Units) Forecast by Country, 2019 to 2034
Table 39: East Asia Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 40: East Asia Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 41: East Asia Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 42: East Asia Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 43: East Asia Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 44: East Asia Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 45: East Asia Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 46: East Asia Market Volume (Units) Forecast by Application, 2019 to 2034
Table 47: East Asia Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 48: East Asia Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 49: South Asia & Pacific Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 50: South Asia & Pacific Market Volume (Units) Forecast by Country, 2019 to 2034
Table 51: South Asia & Pacific Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 52: South Asia & Pacific Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 53: South Asia & Pacific Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 54: South Asia & Pacific Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 55: South Asia & Pacific Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 56: South Asia & Pacific Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 57: South Asia & Pacific Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 58: South Asia & Pacific Market Volume (Units) Forecast by Application, 2019 to 2034
Table 59: South Asia & Pacific Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 60: South Asia & Pacific Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 61: Western Europe Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 62: Western Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 63: Western Europe Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 64: Western Europe Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 65: Western Europe Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 66: Western Europe Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 67: Western Europe Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 68: Western Europe Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 69: Western Europe Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 70: Western Europe Market Volume (Units) Forecast by Application, 2019 to 2034
Table 71: Western Europe Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 72: Western Europe Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 73: Eastern Europe Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 74: Eastern Europe Market Volume (Units) Forecast by Country, 2019 to 2034
Table 75: Eastern Europe Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 76: Eastern Europe Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 77: Eastern Europe Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 78: Eastern Europe Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 79: Eastern Europe Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 80: Eastern Europe Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 81: Eastern Europe Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 82: Eastern Europe Market Volume (Units) Forecast by Application, 2019 to 2034
Table 83: Eastern Europe Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 84: Eastern Europe Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
Table 85: Middle East & Africa Market Value (US$ Mn) Forecast by Country, 2019 to 2034
Table 86: Middle East & Africa Market Volume (Units) Forecast by Country, 2019 to 2034
Table 87: Middle East & Africa Market Value (US$ Mn) Forecast by RAS Type, 2019 to 2034
Table 88: Middle East & Africa Market Volume (Units) Forecast by RAS Type, 2019 to 2034
Table 89: Middle East & Africa Market Value (US$ Mn) Forecast by End Users vs Kits Type, 2019 to 2034
Table 90: Middle East & Africa Market Volume (Units) Forecast by End Users vs Kits Type, 2019 to 2034
Table 91: Middle East & Africa Market Value (US$ Mn) Forecast by Detection Methods, 2019 to 2034
Table 92: Middle East & Africa Market Volume (Units) Forecast by Detection Methods, 2019 to 2034
Table 93: Middle East & Africa Market Value (US$ Mn) Forecast by Application, 2019 to 2034
Table 94: Middle East & Africa Market Volume (Units) Forecast by Application, 2019 to 2034
Table 95: Middle East & Africa Market Value (US$ Mn) Forecast by Cancer Type, 2019 to 2034
Table 96: Middle East & Africa Market Volume (Units) Forecast by Cancer Type, 2019 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 02: Global Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 03: Global Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 04: Global Market Value (US$ Mn) by Application, 2024 to 2034
Figure 05: Global Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 06: Global Market Value (US$ Mn) by Region, 2024 to 2034
Figure 07: Global Market Value (US$ Mn) Analysis by Region, 2019 to 2034
Figure 08: Global Market Volume (Units) Analysis by Region, 2019 to 2034
Figure 09: Global Market Value Share (%) Analysis by Region, 2024 to 2034
Figure 10: Global Market Y-o-Y Growth (%) Projections by Region, 2024 to 2034
Figure 11: Global Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 12: Global Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 13: Global Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 14: Global Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 15: Global Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 16: Global Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 17: Global Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 18: Global Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 19: Global Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 20: Global Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 21: Global Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 22: Global Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 23: Global Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 24: Global Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 25: Global Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 26: Global Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 27: Global Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 28: Global Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 29: Global Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 30: Global Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 31: Global Market Attractiveness by RAS Type, 2024 to 2034
Figure 32: Global Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 33: Global Market Attractiveness by Detection Methods, 2024 to 2034
Figure 34: Global Market Attractiveness by Application, 2024 to 2034
Figure 35: Global Market Attractiveness by Cancer Type, 2024 to 2034
Figure 36: Global Market Attractiveness by Region, 2024 to 2034
Figure 37: North America Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 38: North America Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 39: North America Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 40: North America Market Value (US$ Mn) by Application, 2024 to 2034
Figure 41: North America Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 42: North America Market Value (US$ Mn) by Country, 2024 to 2034
Figure 43: North America Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 44: North America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 45: North America Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 46: North America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 47: North America Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 48: North America Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 49: North America Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 50: North America Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 51: North America Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 52: North America Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 53: North America Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 54: North America Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 55: North America Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 56: North America Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 57: North America Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 58: North America Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 59: North America Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 60: North America Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 61: North America Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 62: North America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 63: North America Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 64: North America Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 65: North America Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 66: North America Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 67: North America Market Attractiveness by RAS Type, 2024 to 2034
Figure 68: North America Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 69: North America Market Attractiveness by Detection Methods, 2024 to 2034
Figure 70: North America Market Attractiveness by Application, 2024 to 2034
Figure 71: North America Market Attractiveness by Cancer Type, 2024 to 2034
Figure 72: North America Market Attractiveness by Country, 2024 to 2034
Figure 73: Latin America Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 74: Latin America Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 75: Latin America Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 76: Latin America Market Value (US$ Mn) by Application, 2024 to 2034
Figure 77: Latin America Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 78: Latin America Market Value (US$ Mn) by Country, 2024 to 2034
Figure 79: Latin America Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 80: Latin America Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 81: Latin America Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 82: Latin America Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 83: Latin America Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 84: Latin America Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 85: Latin America Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 86: Latin America Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 87: Latin America Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 88: Latin America Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 89: Latin America Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 90: Latin America Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 91: Latin America Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 92: Latin America Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 93: Latin America Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 94: Latin America Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 95: Latin America Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 96: Latin America Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 97: Latin America Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 98: Latin America Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 99: Latin America Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 100: Latin America Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 101: Latin America Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 102: Latin America Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 103: Latin America Market Attractiveness by RAS Type, 2024 to 2034
Figure 104: Latin America Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 105: Latin America Market Attractiveness by Detection Methods, 2024 to 2034
Figure 106: Latin America Market Attractiveness by Application, 2024 to 2034
Figure 107: Latin America Market Attractiveness by Cancer Type, 2024 to 2034
Figure 108: Latin America Market Attractiveness by Country, 2024 to 2034
Figure 109: East Asia Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 110: East Asia Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 111: East Asia Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 112: East Asia Market Value (US$ Mn) by Application, 2024 to 2034
Figure 113: East Asia Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 114: East Asia Market Value (US$ Mn) by Country, 2024 to 2034
Figure 115: East Asia Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 116: East Asia Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 117: East Asia Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 118: East Asia Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 119: East Asia Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 120: East Asia Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 121: East Asia Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 122: East Asia Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 123: East Asia Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 124: East Asia Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 125: East Asia Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 126: East Asia Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 127: East Asia Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 128: East Asia Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 129: East Asia Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 130: East Asia Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 131: East Asia Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 132: East Asia Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 133: East Asia Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 134: East Asia Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 135: East Asia Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 136: East Asia Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 137: East Asia Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 138: East Asia Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 139: East Asia Market Attractiveness by RAS Type, 2024 to 2034
Figure 140: East Asia Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 141: East Asia Market Attractiveness by Detection Methods, 2024 to 2034
Figure 142: East Asia Market Attractiveness by Application, 2024 to 2034
Figure 143: East Asia Market Attractiveness by Cancer Type, 2024 to 2034
Figure 144: East Asia Market Attractiveness by Country, 2024 to 2034
Figure 145: South Asia & Pacific Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 146: South Asia & Pacific Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 147: South Asia & Pacific Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 148: South Asia & Pacific Market Value (US$ Mn) by Application, 2024 to 2034
Figure 149: South Asia & Pacific Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 150: South Asia & Pacific Market Value (US$ Mn) by Country, 2024 to 2034
Figure 151: South Asia & Pacific Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 152: South Asia & Pacific Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 153: South Asia & Pacific Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 154: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 155: South Asia & Pacific Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 156: South Asia & Pacific Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 157: South Asia & Pacific Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 158: South Asia & Pacific Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 159: South Asia & Pacific Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 160: South Asia & Pacific Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 161: South Asia & Pacific Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 162: South Asia & Pacific Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 163: South Asia & Pacific Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 164: South Asia & Pacific Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 165: South Asia & Pacific Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 166: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 167: South Asia & Pacific Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 168: South Asia & Pacific Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 169: South Asia & Pacific Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 170: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 171: South Asia & Pacific Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 172: South Asia & Pacific Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 173: South Asia & Pacific Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 174: South Asia & Pacific Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 175: South Asia & Pacific Market Attractiveness by RAS Type, 2024 to 2034
Figure 176: South Asia & Pacific Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 177: South Asia & Pacific Market Attractiveness by Detection Methods, 2024 to 2034
Figure 178: South Asia & Pacific Market Attractiveness by Application, 2024 to 2034
Figure 179: South Asia & Pacific Market Attractiveness by Cancer Type, 2024 to 2034
Figure 180: South Asia & Pacific Market Attractiveness by Country, 2024 to 2034
Figure 181: Western Europe Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 182: Western Europe Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 183: Western Europe Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 184: Western Europe Market Value (US$ Mn) by Application, 2024 to 2034
Figure 185: Western Europe Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 186: Western Europe Market Value (US$ Mn) by Country, 2024 to 2034
Figure 187: Western Europe Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 188: Western Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 189: Western Europe Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 190: Western Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 191: Western Europe Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 192: Western Europe Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 193: Western Europe Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 194: Western Europe Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 195: Western Europe Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 196: Western Europe Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 197: Western Europe Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 198: Western Europe Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 199: Western Europe Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 200: Western Europe Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 201: Western Europe Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 202: Western Europe Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 203: Western Europe Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 204: Western Europe Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 205: Western Europe Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 206: Western Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 207: Western Europe Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 208: Western Europe Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 209: Western Europe Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 210: Western Europe Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 211: Western Europe Market Attractiveness by RAS Type, 2024 to 2034
Figure 212: Western Europe Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 213: Western Europe Market Attractiveness by Detection Methods, 2024 to 2034
Figure 214: Western Europe Market Attractiveness by Application, 2024 to 2034
Figure 215: Western Europe Market Attractiveness by Cancer Type, 2024 to 2034
Figure 216: Western Europe Market Attractiveness by Country, 2024 to 2034
Figure 217: Eastern Europe Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 218: Eastern Europe Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 219: Eastern Europe Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 220: Eastern Europe Market Value (US$ Mn) by Application, 2024 to 2034
Figure 221: Eastern Europe Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 222: Eastern Europe Market Value (US$ Mn) by Country, 2024 to 2034
Figure 223: Eastern Europe Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 224: Eastern Europe Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 225: Eastern Europe Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 226: Eastern Europe Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 227: Eastern Europe Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 228: Eastern Europe Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 229: Eastern Europe Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 230: Eastern Europe Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 231: Eastern Europe Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 232: Eastern Europe Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 233: Eastern Europe Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 234: Eastern Europe Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 235: Eastern Europe Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 236: Eastern Europe Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 237: Eastern Europe Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 238: Eastern Europe Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 239: Eastern Europe Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 240: Eastern Europe Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 241: Eastern Europe Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 242: Eastern Europe Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 243: Eastern Europe Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 244: Eastern Europe Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 245: Eastern Europe Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 246: Eastern Europe Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 247: Eastern Europe Market Attractiveness by RAS Type, 2024 to 2034
Figure 248: Eastern Europe Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 249: Eastern Europe Market Attractiveness by Detection Methods, 2024 to 2034
Figure 250: Eastern Europe Market Attractiveness by Application, 2024 to 2034
Figure 251: Eastern Europe Market Attractiveness by Cancer Type, 2024 to 2034
Figure 252: Eastern Europe Market Attractiveness by Country, 2024 to 2034
Figure 253: Middle East & Africa Market Value (US$ Mn) by RAS Type, 2024 to 2034
Figure 254: Middle East & Africa Market Value (US$ Mn) by End Users vs Kits Type, 2024 to 2034
Figure 255: Middle East & Africa Market Value (US$ Mn) by Detection Methods, 2024 to 2034
Figure 256: Middle East & Africa Market Value (US$ Mn) by Application, 2024 to 2034
Figure 257: Middle East & Africa Market Value (US$ Mn) by Cancer Type, 2024 to 2034
Figure 258: Middle East & Africa Market Value (US$ Mn) by Country, 2024 to 2034
Figure 259: Middle East & Africa Market Value (US$ Mn) Analysis by Country, 2019 to 2034
Figure 260: Middle East & Africa Market Volume (Units) Analysis by Country, 2019 to 2034
Figure 261: Middle East & Africa Market Value Share (%) Analysis by Country, 2024 to 2034
Figure 262: Middle East & Africa Market Y-o-Y Growth (%) Projections by Country, 2024 to 2034
Figure 263: Middle East & Africa Market Value (US$ Mn) Analysis by RAS Type, 2019 to 2034
Figure 264: Middle East & Africa Market Volume (Units) Analysis by RAS Type, 2019 to 2034
Figure 265: Middle East & Africa Market Value Share (%) Analysis by RAS Type, 2024 to 2034
Figure 266: Middle East & Africa Market Y-o-Y Growth (%) Projections by RAS Type, 2024 to 2034
Figure 267: Middle East & Africa Market Value (US$ Mn) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 268: Middle East & Africa Market Volume (Units) Analysis by End Users vs Kits Type, 2019 to 2034
Figure 269: Middle East & Africa Market Value Share (%) Analysis by End Users vs Kits Type, 2024 to 2034
Figure 270: Middle East & Africa Market Y-o-Y Growth (%) Projections by End Users vs Kits Type, 2024 to 2034
Figure 271: Middle East & Africa Market Value (US$ Mn) Analysis by Detection Methods, 2019 to 2034
Figure 272: Middle East & Africa Market Volume (Units) Analysis by Detection Methods, 2019 to 2034
Figure 273: Middle East & Africa Market Value Share (%) Analysis by Detection Methods, 2024 to 2034
Figure 274: Middle East & Africa Market Y-o-Y Growth (%) Projections by Detection Methods, 2024 to 2034
Figure 275: Middle East & Africa Market Value (US$ Mn) Analysis by Application, 2019 to 2034
Figure 276: Middle East & Africa Market Volume (Units) Analysis by Application, 2019 to 2034
Figure 277: Middle East & Africa Market Value Share (%) Analysis by Application, 2024 to 2034
Figure 278: Middle East & Africa Market Y-o-Y Growth (%) Projections by Application, 2024 to 2034
Figure 279: Middle East & Africa Market Value (US$ Mn) Analysis by Cancer Type, 2019 to 2034
Figure 280: Middle East & Africa Market Volume (Units) Analysis by Cancer Type, 2019 to 2034
Figure 281: Middle East & Africa Market Value Share (%) Analysis by Cancer Type, 2024 to 2034
Figure 282: Middle East & Africa Market Y-o-Y Growth (%) Projections by Cancer Type, 2024 to 2034
Figure 283: Middle East & Africa Market Attractiveness by RAS Type, 2024 to 2034
Figure 284: Middle East & Africa Market Attractiveness by End Users vs Kits Type, 2024 to 2034
Figure 285: Middle East & Africa Market Attractiveness by Detection Methods, 2024 to 2034
Figure 286: Middle East & Africa Market Attractiveness by Application, 2024 to 2034
Figure 287: Middle East & Africa Market Attractiveness by Cancer Type, 2024 to 2034
Figure 288: Middle East & Africa Market Attractiveness by Country, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the RAS mutation detection kit market in 2024?
The global RAS mutation detection kit market is estimated at US$ 118.7 million in 2024.
What is the sales value of RAS mutation detection kit solutions in Brazil?
Sales of RAS mutation detection kits in Brazil are calculated at US$ 1.7 million for 2024.
What is the projected revenue from RAS mutation detection kit sales by 2034?
Worldwide revenue from RAS mutation detection kits sales is forecasted to reach US$ 246.7 million by 2034 end.
What is the demand growth projection for the global market?
Demand for RAS mutation detection kits solutions is forecasted to rise at a CAGR of 7.6% during the next 10 years.
Which RAS mutation detection kit type is most widely preferred?
Tissue-based kits are widely popular due to their efficiency and safe results.
Who are the key players in the RAS mutation detection kits?
Leading companies in the market are EntroGen Inc., QIAGEN, Roche Molecular Diagnostics, Bio-Rad Laboratories, Personalis, and Thermo Fisher Scientific.
RAS Mutation Detection Kit Market